Structure and function of a novel antioxidant peptide from the skin of tropical frogs by Barbosa, Eder Alves et al.
Structure and function of a novel antioxidant peptide from the skin of
tropical frogs
Eder Alves Barbosaa,b, Ana Oliveirac, Alexandra Plácidod, Renato Socodatoe, Camila C. Portugale,
Ana Carolina Mafudf,g, Alicia S. Ombredaneh, Daniel C. Moreirai, Nuno Valej, Lucinda J. Bessak,
Graziella A. Joanittih,l, Cláudia Alvesk, Paula Gomesk, Cristina Delerue-Matosd,
Yvonne Primerano Mascarenhasf, Mariela M. Maranim, João B. Relvase, Manuela Pintadoc,
José Roberto S.A. Leitee,i,⁎
a Laboratório de Espectrometria de Massa, EMBRAPA Recursos Genéticos e Biotecnologia, Brasília, Brazil
b Laboratório de Síntese e Análise de Biomoléculas, Instituto de Química, Universidade de Brasília, Brasília, Brazil
c Centro de Biotecnologia e Química Fina, CBQF, Universidade Católica Portuguesa, Rua Arquiteto Lobão Vital Apartado, 2511, Asprela, Porto, Portugal
d LAQV/REQUIMTE, GRAQ, Instituto Superior de Engenha do Porto, ISEP, Porto, Portugal
eGlial Cell Biology Lab, Instituto de Investigação e Inovação em Saúde and Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal
f Instituto de Física de São Carlos, IFSC, Universidade de São Paulo, USP, São Carlos, SP, Brazil
g Dept Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel 4051, Switzerland
h Laboratório de Nanobiotecnologia, Instituto de Biologia, Campus Darcy Ribeiro, UnB, Brasília, DF, Brazil
i Área de Morfologia, Faculdade de Medicina, Universidade de Brasília, UnB, Brasília, DF, Brazil
jUCIBIO/REQUIMTE, Laboratório de Farmacologia, Departamento de Ciências do Medicamento, Faculdade de Farmácia da Universidade do Porto, Rua de Jorge Viterbo
Ferreira, 228, 4050-313 Porto, Portugal
k LAQV/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências da Universidade do Porto, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal
l Campus Ceilândia, Centro Metropolitano, UnB, Ceilândia, Brasília, DF, Brazil
m IPEEC-CONICET, Consejo Nacional de Investigaciones Científicas y Técnicas, Puerto Madryn, Argentina
Keywords:
Amphibia
Antioxidant peptide
Antioxidin
Microglia
Reactive oxygen species
Skin secretion
A B S T R A C T
The amphibian skin plays an important role protecting the organism from external harmful factors such as
microorganisms or UV radiation. Based on biorational strategies, many studies have investigated the cutaneous
secretion of anurans as a source of bioactive molecules. By a peptidomic approach, a novel antioxidant peptide
(AOP) with in vitro free radical scavenging ability was isolated from Physalaemus nattereri. The AOP, named
antioxidin-I, has a molecular weight [M+H]+ = 1543.69 Da and a TWYFITPYIPDK primary amino acid se-
quence. The gene encoding the antioxidin-I precursor was expressed in the skin tissue of three other Tropical frog
species: Phyllomedusa tarsius, P. distincta and Pithecopus rohdei. cDNA sequencing revealed highly homologous
regions (signal peptide and acidic region). Mature antioxidin-I has a novel primary sequence with low similarity
compared with previously described amphibian's AOPs. Antioxidin-I adopts a random structure even at high
concentrations of hydrophobic solvent, it has poor antimicrobial activity and poor performance in free radical
scavenging assays in vitro, with the exception of the ORAC assay. However, antioxidin-I presented a low cyto-
toxicity and suppressed menadione-induced redox imbalance when tested with fibroblast in culture. In addition,
it had the capacity to substantially attenuate the hypoxia-induced production of reactive oxygen species when
tested in hypoxia exposed living microglial cells, suggesting a potential neuroprotective role for this peptide.
1. Introduction
Amphibian's skin constitutes a water and gas permeable thin barrier
between the organism and the environment. Physiological skin roles
include gas exchange, excretion, thermoregulation, and reproduction
[1]. Additionally, the amphibian skin presents an important defensive
function against predators, bacteria and fungi. These are particularly
relevant in the light of the natural history of amphibians. Most am-
phibians inhabit moist or aquatic habitats and the constantly humid
skin represents an adequate media for bacterial and fungal growth.
Over the last decades, one of the most investigated features of the
amphibian's skin was related to the innate immune system. Amphibian
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species developed a protection mechanism based on the production and
storage of antimicrobial peptides by specialized granular glands spread
throughout the skin that protects skin tissue against microorganism
infection [2]. These glands also produce a set of biomolecules having
distinct structures and well-established activities e.g. vasodilatation,
hypotension [3,4] and endopeptidase inhibition [5]. This molecular
arsenal protects these animals not only from microorganisms but also
from predators and other abiotic threats [6].
By employing a biorational approach (i.e. predict the presence of
compounds with potential pharmacological applications based on or-
ganisms’ interactions with the environment) a great number of bioac-
tive molecules from amphibian skin have been described, most of them
with, but not limited to, antimicrobial activity [7]. Many amphibians
transit between aquatic and terrestrial habitats, which expose the ani-
mal's skin to wide variations in O2 availability. Moreover, during day
light the delicate amphibian skin, lacking an external protective layer
and with a thin stratum corneum, is exposed to UV radiation. Both, UV
exposure and drastic changes in O2 exposure have been linked with
altered reactive oxygen species (ROS) generation. Therefore, it could be
predicted, using a biorational approach, that amphibian skin secretion
would have a molecular mechanism to minimize the threat from these
sources. Pheomelanin, a melanin type protein, present in the skin of
Hymenochirus boettgeri, is an example of a protector molecule against
UV light damage in amphibians [8]. Indeed, a collection of peptides
with antioxidant activity in chemical systems isolated from the skin
secretion of Asiatic frogs has been recently reported [9–11]. In general,
a great variability of structures was found among the species studied
[9,10,12], suggesting that these peptides did not arise from a common
ancestor molecule.
In biological systems, antioxidant networks manage the steady state
of reactive species [13]. Reactive species, including ROS, are important
signals that participate in many physiological processes [14–16]. There
are several cellular pathways that lead to ROS production, including
mitochondrial electron transport chain, NADPH oxidases and several
other enzymatic reactions (e.g. oxidases) [13]. The rate of ROS forma-
tion from such sources responds intra and extracellular stimuli. For
example, hypoxia exposure [17] and reperfusion after an ischemic
event [18] elicit an overproduction of mitochondrial ROS. Thus, the
constantly produced ROS and their control by antioxidants constitute a
redox signaling mechanism, in which reversible oxidation of en-
dogenous thiols has a central role [19]. In some situations, excess ROS
may overcome the management capacity of antioxidants, leading to a
redox imbalance. Due to their reactivity, excess ROS may cause irre-
versible oxidative damage to biomolecules, which may have signaling
functions, but also cause loss of function [20]. The disruption of sig-
naling pathways and accumulation of oxidatively modified molecules
have been linked to several neurodegenerative disorders, such as Alz-
heimer's disease [21], Parkinson's disease [22], Huntington disease [23]
and Amyotrophic Lateral Sclerosis [24].
In this work, we predicted the presence of peptides with antioxidant
activity in the cutaneous secretion from the tropical frog Physalaemus
nattereri (Steindachner, 1863). We used chromatography, tandem mass
spectrometry, molecular biology and in silico techniques followed by in
vitro assays to characterize antioxidin-I, a peptide isolated from the
tropical frog P. nattereri with potential antioxidant activity. We de-
monstrated the expression of this peptide in other tropical frogs of the
Phyllomedusa and Pithecopus genus: Phyllomedusa tarsius, P. distincta
and Pithecopus rohdei. Then, aiming at the potential pharmaceutical use
of this peptide, we conducted viability and antioxidant assays in cell
culture. We tested the ability of the peptide to mitigate menadione-
induced redox imbalance in fibroblasts and the capacity to suppress
ROS levels in hypoxia-exposed microglia.
2. Material and methods
2.1. Isolation and characterization of the antioxidin-I
Adult Phyllomedusa distincta, P. tarsius, Pithecopus rohdei (first as-
sessed under the generic name Phyllomedusa, but has been transferred
to the genus Pithecopus by Duellman et al. [25]) and Physalaemus
nattereri specimens were captured manually in the Brazilian Atlantic
forest of Santa Catarina and São Paulo, Tropical forest of Amazônia and
Cerrado of Goiás, respectively, under the license N°240/2005-CGFAU
from the Instituto Brasileiro e dos Recursos Renováveis – IBAMA
(Process No. 034/06-COFAN). The cutaneous secretion from Physa-
laemus nattereri was obtained by electrical stimulation (6 V), collected
with Milli-Q water in 50 mL tubes, filtrated (Millipore filters, 0.22 µm)
and immediate frozen and lyophilized.
The P. nattereri dry secretion (1 mg) was dissolved in Milli-Q water
(500 μL) and subjected to an HPLC system (Shimadzu Co., LC-20 CE
model), using a Vydac C18 reverse phase column (2018 TP). The
fractions were eluted with a linear gradient of 0.1% (v/v) TFA/acet-
onitrile ranging from 5% to 60% over 60 min and 75–95% over 5 min at
a flow rate of 1 mL/min. Fractions were monitored at 216 and 280 nm,
collected in tubes and dried under vacuum centrifugation.
Dried fractions were re-dissolved in Milli-Q water. The amount of
solvent, ranged from 10 to 100 μL, was adjust according to the absor-
bance value previously obtained for each fraction. One microliter ali-
quot of the chromatographic fractions was dissolved in α-cyano-4-hy-
droxicinamic acid matrix solution (1:3, v/v) and then applied on the
MALDI plate. The molecular mass of the peptides was determined by
MALDI-TOF/MS using the UltraFlex Xtreme mass spectrometer (Bruker
Daltonics) in the positive reflected mode, controlled by the FlexControl
software. The ions of interest were fragmented in the LIFT mode (MS/
MS), aiming the de novo sequencing of peptides. Before each analysis,
the spectrometer was calibrated using a mixture of peptides. The
spectra were analyzed manually using the FlexAnalysis software
(Bruker Daltonics). Amino acid sequencing data were compared with
cDNA sequencing analyses.
2.2. cDNA sequencing
Three specimens from each amphibian species were euthanized by
infusion of 2% liquid lidocaine hydrochloride solution (100 μL) directly
into the brain [26]. The dorsal cutaneous tissues were isolated by dis-
section. The inguinal glands of P. nattereri were dissected separately
from dorsal skin. Tissues for RNA extraction were immediately frozen in
liquid nitrogen and stored at −80 °C. The cDNA characterization and
analysis were performed as previously reported (Brand et al., 2006).
Briefly, the isolated tissues were pulverized in liquid nitrogen and ap-
proximately 10 mg of the resulted powder were used for extraction of
the total RNA using the Trizol reagent (Invitrogen) according to the
manufacturer's instructions. One microgram of RNA was subjected to
cDNA synthesis with the enzyme ImProm II (Promega), according to the
manufacturer's protocol. Degenerate oligonucleotides (Table S1) were
used for PCR reactions.
PCR products were run by electrophoresis in 1% agarose gel for
analysis of the amplified fragments. Those having molecular weights
between 250 and 400 bp were isolated and purified with Wizard SV Gel
and PCR Clean-Up System (Promega), following manufacturer's in-
structions. The purified DNA samples were subjected to the pGEM-T
Easy (Promega) vector binding reaction, according to manufacturer's
instructions, and transfected into E. coli (DH5α) by electroporation.
After selecting the clones of interest, the plasmids were isolated and
submitted to automatic nucleotide sequencing (Sanger sequencing
method).
2.3. Relative expression assays by qPCR
The nucleotide sequences of the precursor of interest were used as a
template for the design and synthesis of specific oligonucleotides tar-
geting relative gene expression assays by means of real-time PCR (RT-
PCR), performed as previously reported [6]. Briefly, the total RNA
constituting the dorsal cutaneous tissue and the inguinal glands of P.
nattereri were extracted separately. A fraction of cDNA, synthesized
with Oligo-dT, was diluted in nano pure H2O (1:25). This solution was
used as template in the qPCR assays, which were performed on a 7500
Fast RT-PCR System (Applied Biosystems) in Relative Quantification
Plate mode. Platinum SYBR Green qPCR SuperMix-UDG with ROX
(Invitrogen) was used in the preparation of reactions, as described by
the manufacturer, in which the specific oligonucleotides synthesized
were added (Table S1). Expression of the gene encoding the actin
protein was used as a normalizer. At the end of each reaction, the
dissociation cycle was performed to verify the specificity of the oligo-
nucleotides. The experiment was carried out in triplicate. Statistical
analyses of the results were done according to the manual suggested by
Applied Biosystems.
2.4. Density functional theory
Density Functional Theory (DFT) [27] calculations were performed
to optimize the structures. The B3LYP [28,29] exchange-correlation
functional was chosen and the basis set used was the 6–311 G with two
polarization functions (d,p) and diffuse functions for hydrogen (++)
[30], as implemented in the Gaussian 09 software [31].
2.5. Peptide synthesis
Peptide (C-terminal amide) was assembled by Fmoc/tBu solid-phase
peptide synthesis (SPPS) methodologies assisted with microwave (MW)
energy, using a Liberty Microwave Peptide Synthesizer (CEM
Corporation, Mathews, NC, USA). The Rink amide resin was pre-
conditioned for 15 min in N,N-dimethylformamide (DMF) and then
transferred into the MW-reaction vessel. The initial Fmoc deprotection
step was carried out using 20% piperidine in DMF containing 0.1 M of
1-hydroxybenzotriazole (HOBt) in two MW irradiation pulses: 30 s at
24 W plus 3 min at 28 W, in both cases temperature being no higher
than 75 °C. The C-terminal amino acid was coupled to the deprotected
Rink amide resin, using 5 M equivalents (eq) of the Fmoc-protected
amino acid in DMF (0.2 M), 5 eq of 0.5 M HBTU/HOBt in DMF, and 10
eq of 2 M N-ethyl-N,N-diisopropylamine (DIPEA) in N-methylpyrroli-
done (NMP). The coupling step was carried out for 5 min at 35 W MW
irradiation, with the maximum temperature reaching 75 °C. Remaining
amino acids were sequentially coupled in the C→N direction by means
of similar deprotection and coupling cycles. Following completion of
the sequence assembly, the peptide was released from the resin with
concomitant removal of side-chain protecting groups, by a 1.5 h acid-
olysis at room temperature using a trifluoroacetic acid (TFA)-based
cocktail containing triisopropysilane (TIS) and water (95:2.5:2.5, v/v/
v) as scavengers.
For MS analysis, samples were separated on an HPLC Accela
(Thermo Fischer Scientific, Bremen, Germany) with a C18 Nucleodur
gravity column (Macherey-Nagel, USA) (5 µm 4 mm × 125 mm) using
a gradient of CH3CN. Starting with 100% solvent A (H2O/0.1% (v/v)
TFA) and rising to 100% Solvent B (CH3CN) over 30 min at a flow rate
of 1.0 mL/min. MS analysis was performed on an LTQ OrbitrapTM XL
hybrid mass spectrometer (Thermo Fischer Scientific, Bremen,
Germany) controlled by LTQ Tune Plus 2.5.5 and Xcalibur 2.1.0.
Electrospray ionization source settings (ESI) were as follows: source
voltage, 3.1 kV; the capillary temperature was 275 °C with a sheath gas
flow rate at 40 and auxiliary gas flow rate at 10 (arbitrary unit as
provided by the software settings). The capillary voltage was 36 V and
the tube lens voltage 110 V. MS data handling software (Xcalibur
QualBrowser software, Thermo Fischer Scientific) was used to obtain
the confirmation of the synthetic peptide by their exact m/z value.
Peptides purity were determined by HPLC, using a Hitachi-Merck
LaChrom Elite system equipped with a quaternary pump, a temperature
controlled automated sampler, and a diode-array detector (DAD).
Peptides were purified by preparative HPLC system (LaPrep Sigma),
with LP1100 Quaternary LPG pump injection with fractionation valve,
using 0.05% TFA water solution/CH3CN mixtures as the mobile phase.
Both peptides were obtained with correct mass spectra data and high
chromatographic purity.
2.6. Sequence analysis
The peptide sequence obtained was compared with the anti-
microbial peptide deposited at the antimicrobial peptide database [32].
The program ProtParam was used for computation of physical and
chemical parameters (MW, theoretical pI, instability index, aliphatic
index, and grand average of hydropathicity, GRAVY). The HeliQuest
program was used to calculate hydrophobic moments (µH) and helix
wheel projections.
2.7. Structural studies
Three-dimensional structural model predictions of the peptides
were obtained using the internet resources PEP-FOLD. Secondary
structure content was studied by circular dichroism spectroscopy in the
far UV wavelengths, using a JASCO J 815 instrument (Jasco Corp.,
Tokyo, Japan). The measurements were performed under nitrogen gas
flow of 8 L/h at 20 °C, controlled by a Peltier system (JASCO). Spectra
were recorded between 190 and 260 nm, using a 100 mm cell path
length. The peptides were dissolved in either Milli-Q water or 2,2,2-
trifluoethanol (TFE) (10, 20 or 40%) at 80 μM final concentration. The
instrument was set at 50 nm/min scan speed, 1 s response time and
1 nm bandwidth. The spectra were converted to molar ellipticity re-
sidue half by using the relationship: [θ]/θ (10 × c × n × d), where [θ]
is the molar ellipticity (in degrees × cm2 × dmol−1), θ the ellipticity in
mill degrees, n is the number of peptide bonds, c is the molar con-
centration, d is the length of the cell in centimeters.
2.8. Assessment of antimicrobial activity
Antioxidin-I and antioxidin-RP1 (control) peptides were screened
for antibacterial activity against four reference strains, Escherichia coli
ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus
aureus ATCC 25923 and Enterococcus faecalis ATCC 29212. Minimum
inhibitory concentrations (MICs) were determined using a broth mi-
crodilution technique, following the recommendations of the Clinical
and Laboratory Standards Institute (CLSI, 2012). Stock peptide solu-
tions (10 mg/mL) were diluted in Mueller-Hinton broth (MHB-BioKar
Diagnostics, Allonne, France) to achieve concentrations ranging from 4
to 1024 μg/mL. Each bacterial inoculum was prepared in MHB and
standardized in order to obtain a final concentration of 5 × 105 CFU/
mL. Inoculated 96-well plates were incubated at 37 °C for 20–24 h. The
MIC was defined as the lowest concentration of the peptide inhibiting
the visible growth. If a MIC value was within the range of concentra-
tions tested, then the minimum bactericidal concentration (MBC) was
determined by spreading on Mueller-Hinton agar an aliquot of 10 μL
from all wells in which no visible bacterial growth was observed, with
further incubation for 24 h at 37 °C. The lowest concentration at which
no growth occurred on the agar plates was defined as the MBC [33].
Two independent experiments were performed.
2.9. In vitro radical scavenging assays
2.9.1. ABTS assay
Free radical scavenging activity was determined by 2,2-azinobis-3-
ethylbenzothiazoline-6-sulphonic acid (ABTS+) method as described by
Gião et al. [34]. To oxidize the colorless ABTS to the blue-green ABTS+
radical cation, ABTS (7 mM) was mixed with potassium persulfate
(2.45 mM) and kept for 12–16 h at room temperature in the dark. The
ABTS solution was diluted with water to an absorbance of 0.70
(± 0.02) at 734 nm (Shimadzu 1240 UV–visible spectrophotometer).
The absorbance reading was exactly 6 min after initial mixing of 1.0 mL
of diluted ABTS+ with 10 μL of peptide solution previously prepared at
0.5 mg/mL for antioxidin-RP1 and at 2 mg/mL for antioxidin-I both in
Milli-Q water. The inhibition (%) of the sample was compared with a
standard curve made from the corresponding readings of trolox (6-hy-
droxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) solutions at dif-
ferent concentrations (20–200 μg/mL) and the results were expressed as
mg of trolox equivalents/mg peptide.
2.9.2. DPPH assay
A stock solution of 1,1-diphenyl-2-picrylhydrazyl (α,α-diphenyl-
bpicrylhydrazyl; DPPH) was prepared in methanol at 60 µM and
checked by measuring an absorbance of 0.6 (± 0.02) at 515 nm
(Shimadzu 1240 UV–visible spectrophotometer). The peptides were
dissolved in Milli-Q water at 0.5 mg/mL for antioxidin-RP1 and at
2 mg/mL for antioxidin-I. Each peptide sample (0.25 mL) was mixed
with 1.75 mL of DPPH and the reaction tubes, in triplicates, were kept
at 25 °C for 30 min in dark. A negative control was performed with
Milli-Q water (0.25 mL) dissolved in 1.75 mL of DPPH and kept under
the same conditions as samples. Spectrophotometric measurements
were done at 515 nm [35]. The inhibition (%) of the sample was
compared with a standard curve made from the corresponding readings
of trolox solutions at different concentrations (3–50 μg/mL) and the
results were expressed as mg of trolox equivalents/mg peptide.
2.9.3. ORAC assay
The fluorescence oxygen radical absorbance capacity (ORAC-FL)
assay was based on that described by Contreras et al. [36]. The reaction
was carried out at 40 °C in 75 mM phosphate buffer (pH 7.4) and the
final assay mixture (200 μL) containing fluorescein (70 nM), AAPH
(14 mM), and trolox (9.98 × 10−4–7.99 × 10−3 μmol/mL) or the
peptide sample (five concentrations between 1 and 40 μg/mL). The
fluorescence was recorded during 137 min (104 cycles). A FLUOstar
OPTIMA plate reader (BMG Labtech, Offenburg, Germany) with
485 nm excitation and 520 nm emission filters was used. The equip-
ment was controlled by the FLUOstar Control software version (1.32
R2) for fluorescence measurements. Black polystyrene 96-well micro-
plates (Nunc, Denmark) were used. AAPH and trolox solutions were
prepared daily and fluorescein was diluted from a stock solution
(1.17 mM) in 75 mM phosphate buffer (pH 7.4). All the reaction mix-
tures were prepared in duplicate and at least three independent mea-
surements were performed for each sample. Final ORAC-FL values were
expressed as mg of trolox equivalent/mg peptide.
2.9.4. Nitric oxide scavenging assay
Griess reagent was used to quantify nitrate and nitrite stable pro-
ducts formation after NO reaction with oxygen under aerobic condi-
tions [37,38]. Sodium nitroprusside (SNP) was used, in aqueous solu-
tion at physiological pH (7.2), to produce NO. The SNP was prepared at
10 mM with phosphate buffer saline (pH 7.4) and mixed with 0.5 mL of
peptide solution. Peptides were both prepared in Milli-Q water at
0.5 mg/mL for antioxidin-RP1 and 2 mg/mL for antioxidin-I The mix-
ture was then incubated at 25 °C for 150 min, then, 0.5 mL of Griess
reagent (Sigma-Aldrich, Sintra, Portugal) was added and the mixture is
incubated at 25 °C for 30 min. Absorbance was measured at 546 nm.
Final values were expressed as mg of trolox equivalent/mg peptide.
2.10. Cytotoxicity assay
Murine fibroblast cells (NIH-3T3) were acquired from cell bank of
Rio de Janeiro (Brazil) and were grown in Dulbecco's Modified Eagle's
Medium (DMEM) (Life, EUA) completed with 10% of heat inactivated
fetal bovine serum (Life, EUA) and 1% of antibiotic solution (100 IU/
mL Penicillin – 100 µg/mL Streptomycin, Life, EUA) at 37 °C and 5%
CO2. For the viability assay, NIH-3T3 cells were seeded into 96-well
culture plate at a density of 3 × 103 cells in DMEM culture medium
overnight at 37 °C, 5% CO2 in humid atmosphere. Then, the medium
was changed and various concentrations of antioxidin-RP1 and anti-
oxidin-I reconstituted in Milli-Q water were applied (400–12.5 µg/mL).
Milli-Q water was used as control. The plates were incubated for 24 h at
37 °C, 5% CO2 in humid atmosphere.
Cell viability assay was carried out using MTT (3-[4, 5-di-
methylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) dry reduction
method. After 24 h of incubation, 15 μL of the MTT solution (5 mg/mL
in phosphate buffer) was added to each well and the plate was in-
cubated for 2 h at 37 °C and 5% CO2 in humid atmosphere. The medium
culture was discarded and 100 μL of DMSO were added to each well.
The absorbance was monitored using a spectrophotometer with a mi-
croplate reader at 595 nm (Molecular Devices, EUA). The morpholo-
gical characterization of fibroblast cells was performed with an inverted
fluorescence microscope EVOS® FL Auto (Life Technology, Waltham,
MA), with magnification of 10X and the images were obtained in phase
contrast mode using EVOS® FL Auto Software v1.7 (REV 32044)
(Thermofisher Scientific).
2.11. Glutathione redox balance experiment
NIH-3T3 cells were seeded in triplicate into 12-well culture plate at
a density of 5 × 104 cells in DMEM culture medium overnight at 37 °C,
5% CO2 in humid atmosphere. Then, 400 µg/mL of antioxidin-I re-
constituted in Milli-Q water were applied and the plates were incubated
at 37 °C, 5% CO2 in humid atmosphere. After 18 h of incubation, 20 µM
of menadione (diluted in ethanol) were added to cells previously ex-
posed or not to antioxidin-I. The plates were incubated for 6 h at 37 °C,
5% CO2 in humid atmosphere. Milli-Q water and ethanol were used as
controls.
For the measurement of glutathione, in its reduced and disulfide
forms, the samples were prepared according to the protocol proposed
by Rahman and coworkers [39]. Cells were washed twice with cold,
Ca2+/Mg2+ free PBS and 500 μL of trypsin–EDTA were added to each
well at room temperature (22–25 °C) for 5 min. One milliliter of cold
DMEM culture medium was added to neutralize the trypsin-EDTA ef-
fect. The cell suspension was centrifuged at 1000×g for 5 min at 4 °C.
The supernatant was discarded and the cell pellet was frozen in liquid
nitrogen and stored at −80 °C until analysis. Cells were suspended in
10% trichloroacetic acid and lysed by three cycles of 1 min ultrasonic
ice-cold bath and 10 s vortex. To safely achieve cell lysis the extract was
frozen at−80 °C and thawed in ice. The cell extract was centrifuged at
10,000×g for 10 min at 4 °C. One aliquot of the supernatant was used
to measure total glutathione and other aliquot for disulfide glutathione
using the enzymatic recycling method [39].
2.12. Hypoxia-induced ROS production in living microglia
2.12.1. Microglial cell line
The human microglial cell line CHME3 was obtained from primary
cultures of human embryonic microglial cells by transfection with a
plasmid encoding for the large T antigen of SV40 [40]. These cells were
previously used in microglial studies demonstrating similar behavior
relative to primary cultures [40]. CHME3 microglia were cultivated as
previously described [41]. In brief, cells were cultured in DMEM Glu-
taMAX™-I, 100 U/mL penicillin, and 100 μg/mL streptomycin supple-
mented with 10% FBS. Cells were kept at 37 °C, 95% air, and 5% CO2 in
a humidified incubator. Cultures were plated on plastic-bottom culture
dishes (μ-Dish 35 mm, iBidi) for live imaging experiments. For the as-
says, microglia were transiently transfected with the HyperRed ROS
biosensor [42] using Jetprime (Polyplus), according to manufacturer's
instructions.
2.12.2. Microscope set-up
Experiments were performed on a fully-motorized DMI6000B mi-
croscope (Leica Microsystems) equipped with filter cubes for cyan
fluorescent protein (CFP) (BP 427/10) and yellow fluorescent protein
(YFP) (BP 504/12) working with specific dichroic (CG1 440/520) and a
separate filter cube for monomeric red fluorescent protein (mRFP) (Ex.
BP580/20; DM 595; Em. 630/55) mounted into a microscope filter
carrousel (Leica fast filter wheels). The excitation light source was a
mercury metal halide bulb integrated with the EL6000 light attenuator.
Cells were observed with a PlanApo 63X 1.3NA glycerol immersion
objective with correction ring. An ORCA-Flash4.0 V2 Digital CMOS
camera (Hamamatsu) coupled to the microscope through a 1.3x c-
mount adapter was used to acquire images. The LAS X software (Leica
Microsystems) controlled all microscope parameters. Shading illumi-
nation was online-corrected for using a shading correction routine
implemented for the LAS X software. At each time point, CFP/CFP
(donor) and CFP/YFP (FRET) images for the HSP FRET sensor or mRFP/
mRFP for HyperRed images were sequentially acquired using 2 × 2
camera binning with an exposure time of 800 ms. A digital small-stage
incubator (iBidi) was used real-time monitoring of environmental
conditions (temperature, gas mixture and humidity) and to maintain
the cells under normoxia (20% O2; 5% CO2; 89–92% humidity) or
subject them to hypoxia (2% O2; 5% CO2; 89–92% humidity).
Transfected cells expressing HyperRed were randomly selected from the
dishes and imaged.
2.12.3. Biosensor quantification
Time-lapse images were exported as 16-bit tiff files and processed in
the FIJI software as before [41,43–45]. In brief, background was dy-
namically subtracted from time-lapses using the rollerball algorithm.
Cells from time-lapses in the Donor to FRET or mRFP channel were
individually segmented and thresholded using the Phansalkar local
threshold algorithm for the generation of black/white binary masks.
Afterwards, cells in the original time-lapse images were multiplied by
their corresponding binary masks and new masked images were gen-
erated in 32-bit floating point tiff images. Masked time-lapses images
were then registered using the StackReg plugin in FIJI. Photobleaching
on the time-lapses was corrected by a bi-exponential fitting curve using
a custom-made FIJI routine. Whole cell HSP Donor/FRET ratio or Hy-
perRed mean gray intensity values throughout the time-lapses were
retrieved and plotted.
2.13. Statistical Analysis
Values were expressed as mean± standard error of the mean
(SEM). The differences in the effects of compound treatment compared
with control values were analyzed by ANOVA and Tukey post-hoc test
using the software Prism®5 (EUA). The significant level was set to
P<0.05.
3. Results and discussion
3.1. Purification and structural characterization of antioxidin
The cutaneous secretion of P. nattereri was fractionated by C18 RT-
HPLC and it resulted in a complex chromatographic profile (Fig. 1).
Aliquots of the 52 chromatogram peaks were analyzed by MALDI-TOF/
MS, subsequently selected ions of interest were fragmented for de novo
sequencing. Antioxidin-I, a peptide with a molecular weight [M+H]+
= 1543.69 Da and a preliminary amino acid sequence TWYFITPYIPDK
with L/I and K/Q ambiguities and a R-COOH C-terminal was identified
(Fig. S1). Peaks with similar retention times, attributed to antioxidin-I,
were also detected in the skin secretion of other tropical frogs. In
parallel, total RNA was extracted from the dorsal skin of P. nattereri, P.
distincta, P. rohdei and P. tarsius and reverse-transcribed to cDNA using
specific primers (Table S1), cloned and sequenced. The sequence of
antioxidin-I precursor was obtained and allowed the solution of L/I and
K/Q ambiguities that remained after de novo peptide sequencing
(Fig. 2). Similar to some peptides with no antimicrobial activity from
frog skin secretions [6,46], the structure of antioxidin-I precursor
contains a conserved signal peptide, an acid piece and an active peptide
region bearing endopeptidase cleavage sites, commonly described to
antimicrobial peptide precursors [47]. These data highlight a conserved
basic design to all, or almost all, active peptide's precursors produced
by granular glands, showing that its structure is not exclusive for an-
timicrobial peptides. Unexpectedly, cDNA sequencing demonstrated
that the four studied frog species express the same mRNA for anti-
oxidin-I with minor polymorphism between nucleotide sequences that
do not affect the amino acid sequence (Fig. 2). Even though the arsenal
of bioactive peptides in the skin of each amphibian species is generally
different, the identification of the same bioactive peptide in more than
one amphibian species was previously reported. Namely, the case of the
antimicrobial peptide dermaseptin 01 [48] originally identified in P.
oreades, that was afterwards also identified in other three species in
same genus: P. azurea, P. nordestina, and P. hypochondrialis [49,50]. In
this work, we report the peptide antioxidin-I that was present in three
genera of tropical amphibians. These observations evidence that anti-
oxidin-I potentially performs an important and an efficient physiolo-
gical role contributing to maintenance of frog's homeostasis.
The usual nomenclature for new AOPs from frog's skin secretions
uses the term “antioxidin” followed by first letter of the two names
comprising the specie name (genus plus specific epitope). For example,
Song et al. [51] described an AOP isolated from Pelophylax ni-
gromaculatus named as antioxidin-PN. Other examples are antioxidin-
RL and antioxidin-RP from Odorrana livida and Rana pleuraden, re-
spectively [9,12]. AOPs that also have antimicrobial activities are
conventionally named as the antimicrobial peptides, e.g. daiyunin-1 and
taipehensin-1 from Amolops daiyunensis and Hylarana taipehensis, re-
spectively [10,11]. The exceptions are AOPs fragilin-A1, fragilin-B1 and
odorranain-Q-Lf isolated from Limnonectes fragilis that do not have
significant antimicrobial activities [52]. Here, we named a new AOP as
antioxidin-I because: 1) the use of first letter of genus and specific
epitope may cause mistakes (antioxidin-PN can be related to e.g. Pelo-
phylax nigromaculatus or Physalaemus nattereri); 2) it is present in four
different frog species comprising three genera and 3) because anti-
oxidin-I do not have antibacterial activities. As the number of AOP
Fig. 1. Reverse phase HPLC chromatogram of the crude extract from P. nattereri skin
secretion. The absorbance was monitored at 216 (black) and 280 nm (red line) in arbi-
trary units (mAU). Fraction containing antioxidin-I is shown with blue arrow. (For in-
terpretation of the references to color in this figure legend, the reader is referred to the
web version of this article).
isolated from frog's skin secretion can increase yet, we suggest that a
new nomenclature for this class of molecules must be proposed.
Antioxidin-I has an unusual sequence unrelated to previously
known families of antioxidant and/or antimicrobial peptides (AMPs),
presenting less than 33.3% of sequence similarity (Table 1) with the
sequences of similar described peptides (tigeninin-1 and temporin-SN4
and –SN2). Analysis in silico showed a neutral net charged molecule,
with no hydrophobic residues on the same surface evidenced by Heli-
Quest (Fig. 4C and D) and reduced sequence similarity in regard to
other characterized peptides (Table 1). As predicted by ADP database
software, antioxidint-I had poor antimicrobial activity (see Anti-
microbial activity section and Table 2). Such observation corroborates
the empirical results obtained by CD analysis that demonstrated the
lack of the typical alpha-helix secondary structure described for AMPs,
even at higher TFE concentrations. Instead, a random structure is
evidenced for antioxidin-I regardless of solvent polarity (Fig. 4A and B).
CD results were consistent with theoretical 3D structure studies per-
formed in silico using the internet resources PEP-FOLD, where it was
observed that the peptide is folded onto itself. The same was observed
for the antioxidin-RP1 structure (Fig. 4E and F). These open structures
could be related to the access to electron transfer and, thus, with a
potential antioxidant activity. Antioxidin-RP1 was chosen as a com-
parative reference peptide because of its reportedly high antioxidant
activity [9]. Accordingly, we performed four different radical scaven-
ging assays with successful results.
3.2. Spatial expression of antioxidin-I in P. nattereri skin
The total RNA samples extracted from inguinal macroglands and
dorsal skin tissue of P. nattereri were used for cDNA synthesis and then
used in qPCR assays. The expression level of the antioxidin-I was higher
in dorsal skin tissue than in inguinal macroglands (Fig. 3), suggesting
that this peptide may have an intrinsic role in the skin of P. nattereri.
Barbosa et al. [6] showed that for P. nattereri, bradykinin gene
Fig. 2. cDNA sequence and predicted amino acid sequences of
antioxidin-I from Phyllomedusa distincta, P. rohdei, P. tarsius and
Physalaemus nattereri. Signal peptide, acid pierce and mature
peptide are in green, orange and blue, respectively. Nucleotide
polymorphisms are highlighted in red. The black dot indicates
stop codon. The asterisks indicate homology. (For interpretation
of the references to color in this figure legend, the reader is re-
ferred to the web version of this article).
Table 1
Primary amino acid sequence of antioxidant peptides, similarity with other peptides se-
quences and additional physicochemical properties for (antioxidin-I).
Peptide Sequence Similaritya (%) Reference
Antioxidin-Ib TWYFIT– –PYIP–DK Present study
Tigerinin-1 – – –FCTMIP–IPRCY 33.30 Sai et al., 2001
Temporin-SN4 – – –FITGLISGLMKAL 31.25 Yang et al., 2013
Temporin-SN2 – – –FITGLIGGLMKAL 31.25 Yang et al., 2013
Antioxidin-RP1c AMRLTYNKPCLYGT Yang et al., 2009
a Percentage of sequence similarity with antioxidin-I.
b Molar absorptivity coefficient a 280 nm: 8250 M-1 cm-1; iso-electric point: pH 6.3; net
charge at pH 7.0: 0; Wimley-White whole-residue hydrophobicity: −2.08 kcal/mol;
protein binding potential (Boman index) 0.37 kcal/mol (Rey, 2009).
c Antioxidin-RP1 was used as a reference of antioxidant peptide (positive control).
Table 2
Antimicrobial activity assessment by minimum inhibitory concentration values (µg/mL)
of antioxidin-I and antioxidin-RP1 against E. coli, P. aeruginosa, S. aureus and E. faecalis.
Peptide Bacterial strain
E. coli P. aeruginosa S. aureus E. faecalis
ATCC 25922 ATCC 27853 ATCC 25923 ATCC 29212
Antioxidin-I > 1024 >1024 >1024 256a
Antioxidin-RP1 >1024 >1024 >1024 >1024
a The minimum bactericidal concentration was> 1024 µg/mL.
transcription and its peptide product were detected mainly in inguinal
macroglands. In this case, bradykinins are produced (and stocked)
mainly by inguinal macroglands waiting for a specific event such as an
attack of a predator. On the other hand, antioxidin-I has a widespread
localization. This is consistent with the hypothetical physiological role
proposed for these peptides, which would be the scavenging of reactive
species overproduced as a result of oxygen availability transitions and
UV radiation exposure (Fig. 4).
3.3. Antimicrobial activity
The antibacterial activity of antioxidin-I and antioxidin-RP1 (used
as a reference) was evaluated against two Gram-negative (Escherichia
coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) and two
Gram-positive (Staphylococcus aureus ATCC 25923 and Enterococcus
faecalis ATCC 29212) strains. As predicted by the APD database tool,
both antioxidin-I and antioxidin-RP1 had no relevant inhibitory activity
against the strains tested (Table 2). Antioxidin-I presented a MIC value
higher than 1024 µg/mL against the Gram-negatives and S. aureus.
Antioxidin-I had a lower MIC (256 µg/mL) against E. faecalis compared
with antioxidin-RP1. The value of 256 µg/mL is still rather high to
foresee antibacterial potential.
3.4. Antioxidant activity theoretical prediction
The prediction indicated that antioxidin-I has 149 atoms and the
molecular formula is C78H38N14O19. Crystallographic data confirmed
the distances of both conventional and unconventional hydrogen bonds
showing no discrepancy in the binding values. The energies obtained
for the neutral and the negative peptide structure were
−5189.08234109 au and −5188.58209572 au respectively. Taking
into account the contribution of each H atom (−0.56119365 au) with
the molecule stabilizing energy and disregarding the contributions
provided by hydrogen bonds, radicals and ions, a comparison of the
structures stabilities was performed (Table S3) (Oliveira et al., 2016).
The comparison shows that the negative peptide is more stable than the
neutral one due to an existing hydrogen connection in the structure.
Both structures show a hydrogen bond closing the structure (Fig. S1).
The hydrogen bond responsible for that closure is stronger in the ne-
gative peptide (Fig. S1B) than in the neutral peptide (Fig. S1A) ex-
plaining the greater stability of the structure (Fig. 5).
3.5. In vitro radical scavenging
Peptides have been shown to act as radical scavengers and such
activity is related to their amino acid composition, sequence, structure,
and hydrophobicity. Aromatic residues (Tyr, Trp, and Phe) are able to
donate electrons while keeping their own stability via resonance
structure [53]. Moreover, His-containing peptides have been shown to
be good radical scavengers [54]. The content of hydrophobic amino
acids is associated with enhanced antioxidative properties, especially
from naturally occurring peptides [55]. In addition, high acidic amino
acid content and their amides may partly be responsible for the strong
antioxidant effects observed due to the presence of excess electrons
[56]. Antioxidin-I and antioxidin-RP1 ability to scavenge radicals in
vitro was evaluated by four different systems (ABTS, DPPH, ORAC and
NO) (Table 3). Antioxidin-RP1 had higher activity than antioxidin-I in
ABTS, DPPH and NO assays. Antioxidin-I was found to cause the highest
inhibition of fluorescein decay, resulting in the highest ORAC value
4.088 mg Trolox/mg of peptide. Antioxidin-I had 136% more anti-
oxidant capacity than antioxidin-RP1 in the ORAC method.
The ORAC assay measures the inhibition of peroxyl radical-induced
oxidations and thus reflects classical radical chain breaking by hy-
drogen transfer. Antioxidant peptides containing aromatic amino acid
residues (Trp and Tyr) in the sequence have strong radical scavenging
activities due to the labile hydrogen atom. Tyr acts as hydrogen donor
by containing hydroxyl, which also exists in polyphenol and synthetic
antioxidants. Most in vitro assays use a stable radical chemically gen-
erated that does not occur in vivo (e.g. ABTS, DPPH); therefore, it may
be more biologically relevant to use radical molecules that are similar
to those occurring in vivo. This is the case of nitric oxide and the peroxyl
radical generated in the ORAC assay [57], which is the method of
choice in the food and pharmaceutical industries [58]. In the case of
antioxidin-RL, the Cys10 is the determinant residue in the radical
scavenging activity of the peptide extracted from Odorrana livida skin
[12]. Many antioxidant peptides with variable structures were isolated
from the skin secretions of R. pleuraden, including the antioxidin-RP1,
which had the highest performance in several radical scavenging ac-
tivity in vitro. Such activity was attributed to the presence of critical
residues of methionine, cysteine, tyrosine and proline [9]. Regardless,
such in vitro assays are highly limited and the interpretation of the
potential activity in vivo should be corroborated by other methods.
3.6. Antioxidin effects on fibroblast viability and redox balance
The cytotoxicity of the peptides antioxidin-I and antioxidin-RP1 was
analyzed by colorimetric MTT assay. Both peptides demonstrated low
cytotoxic activity when exposed to murine fibroblasts cells NIH3T3 at
concentrations from 12.5 to 400 µg/mL for 24 h. The highest decrease
of cell viability was about 20% and was observed at 400 µg/mL of
antioxidin-RP1 (Fig. 6). The evaluation of the cytotoxicity of peptides
isolated from amphibian skin in normal cells is relevant and important
to determine the biocompatibility. Brand and co-workers [50] demon-
strated that peptides isolated from the skin secretion of Phyllomedusa
nordestina had no toxicity against mouse peritoneal macrophages. Ad-
ditionally, low hemolytic and cytotoxic activity were detected in human
erythrocytes and in the murine fibroblasts cell line NIH3T3, after 60 h
exposure to peptides isolated from the skin secretion of the frog Lep-
todactylus pustulatus [59].
Glutathione is the most abundant non-protein thiol in eukaryotic
cells. This tripeptide, in addition to thioredoxin, acts as a redox buffer,
affecting many redox sensitive pathways. In that regard, the ratio be-
tween disulfide (GSSG) and total glutathione (GSH-eq) levels is a good
indicator of the cellular redox balance [60], although one cannot derive
the actual redox potential solely based on glutathione levels [61,62].
We tested the ability of antioxidin-I to avoid redox metabolism dis-
ruption in oxidatively challenged NIH3T3 cells. Menadione treatment
resulted in a more oxidized state in fibroblasts, as indicated by the 8-
Fig. 3. Spatial expression of antioxidin-I precursor in the skin tissue of P. nattereri. The
relative expression was performed by real-time qPCR from two distinct skin regions: in-
guinal macroglands and granular glands (spread on the dorsal surface). (A) Adult speci-
mens of P. nattereri, with indication of inguinal macroglands. (B) Relative expression test
of antioxidin-I precursor by qPCR comparing inguinal macroglands and granular glands.
fold increase in GSSG/GSH-eq ratio (Fig. 7). When cells were pre-in-
cubated with antioxidin-I, the menadione treatment was unable to
cause significant redox imbalance in fibroblasts. Importantly, cell
treatment with antioxidin-I without any other stimulation had no effect
on redox balance.
3.7. Antioxidin effect on hypoxia-induced ROS generation by microglia
Finally, we assessed the antioxidant capacity of antioxidin-I in an-
other cell system. For this, we used microglia, the myeloid resident cells
of the central nervous system (CNS). Microglia respond to tissue da-
mage and infection by producing and releasing reactive oxygen species
(ROS) to the surrounding CNS milieu [63,64]. Therefore, microglia
Fig. 4. Structural analysis of antioxidin-I and antioxidin-RP1 peptides. Circular dichroism of peptides (A) antioxidin-I and (B) antioxidin-RP1 in aqueous and 10%, 20% and 40% of 2,2,2-
trifluoethanol (TFE) solutions (red, blue, green, and orange, respectively). Schiffer and Edmundson wheel projection diagrams of (C) antioxidin-I and (D) antioxidin-RP1 sequences.
Amino acid color code: yellow = unpolar/hydrophobic (Leu, Val), gray= Gly, blue= basic (Lys, Arg), purple = polar without charge (Thr), pink= polar without charge (Asn), green =
Pro. (E) antioxidin-I and (F) antioxidin-RP1 3D structure prediction. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this
article).
constitute an adequate cellular model to test whether antioxidin-I dis-
plays any antioxidant capacity in mammalian cells. Human microglial
cells were subjected to hypoxia, a condition known to induce ROS
production [65], either in the presence or in the absence of antioxidin-I.
We then monitored ROS generation in living microglia by time-lapse
video microscopy using the HyperRed ROS biosensor [42]. Hypoxia
induced a clear production of ROS by microglia (Fig. 8, upper panels
and black line on the graph), however, pre-incubation with 100 µM
antioxidin-I significantly prevented the hypoxia-induced ROS genera-
tion by living microglia (Fig. 8, bottom panels and red line on the
graph). Because such result could be, at least partially, an effect of pH
perturbations, we further confirmed the specificity of antioxidin-I-de-
pendent inhibition of ROS production using a FRET biosensor. This
probe is less sensitive to intracellular pH fluctuations than HyperRed.
As expected, experiments with the HSP FRET sensor in living microglia
confirmed that pre-incubation with 100 µM antioxidin-I abrogated the
generation of ROS triggered by hypoxia (Fig. 8C).
Supplementary material related to this article can be found online at
http://dx.doi.org/10.1016/j.freeradbiomed.2017.11.001.
Stroke is responsible for 10% of all deaths worldwide [66]. It is
estimated that around 25% of stroke patients will not survive beyond
the first month and of those who survive past 6 months, roughly 30%
will require lasting institutional care [66]. On top of that, the lack of
effective treatments for stroke puts great pressure for the development
of new therapeutics, such as the use of neuroprotective molecules, to
attenuate or halt brain damage after stroke [67]. During stroke, there is
a decreased delivery of oxygen to the insulted brain tissue, massive
production of ROS to the surrounding brain milieu and neuronal da-
mage. Microglia become activated by hypoxia [63,64] and start pro-
ducing free radicals in the core of the lesion, which largely contributes
for exacerbating neurotoxicity after stroke. Abrogation of ROS pro-
duction by microglia is therefore claimed to be neuroprotective
[63,64]. Because in the presence of antioxidin-I the generation of ROS
by microglia subjected to hypoxia was impaired, our data suggest a
potential neuroprotective effect for antioxidin-I. Whether antioxidin-I
also displays antioxidant properties in other cells from the brain par-
enchyma, like astrocytes or neurons, and the molecular targets affected
by antioxidin-I in microglia warrants further investigation.
4. Final statements
Herein, antioxidin-I, an antioxidant peptide, was found to be ex-
pressed in the skin of four frog species from three distinct genera. This
peptide had higher antioxidant capacity than antioxidin-RP1 as mea-
sured by the ORAC assay, probably due to the presence of Trp aromatic
residues. On the other hand, antioxidin-I had a lower capacity to sca-
venge the free radicals of ABTS, DPPH and NO than antioxidin-RP1,
probably due to the absence of Cys residues [9,12]. Antioxidin-I pre-
sented antioxidant activity in cell culture assays. It was able to reduce
both menadione-induced redox imbalance in fibroblasts and ROS levels
in hypoxia-challenged microglia. Such observations highlight the cur-
rent view that exogenous antioxidants in biological systems may act
rather as signals instead of free radical scavengers [68]. Antioxidin-I
presented poor radical scavenging activity in three of the four in vitro
assays. In cell culture assay, however, it was able to minimize or avoid
redox imbalance in oxidatively challenged cells. The cellular mechan-
isms that support such effect remain to be elucidated.
The potential health benefits of peptides derived from natural
sources are increasingly attracting interest. They combine low-mole-
cular-weight, high activity, easy absorption, and much reduced
Fig. 5. Optimized structures of neutral (A) and negative (B) peptide from gas phase calculations in the B3LYP//6–311 ++ G** theoretical level, with indication of the hydrogen bonds.
Atom color code: oxygen (red), carbon (gray), hydrogen (white) and nitrogen (blue). (For interpretation of the references to color in this figure legend, the reader is referred to the web
version of this article).
Table 3
Antioxidant capacities of antioxidin-I and antioxidin-RP1 peptides according to different in vitro antioxidant assays. Results are expressed as mg of Trolox equivalent per mg of peptide.
Peptide Antioxidant assay
ABTS DPPH ORAC NO
Antioxidin-I 0.010±0.009 0.0019±0.0004 4.088± 0.214 0.019±0.004
Antioxidin-RP1 0.300±0.002 0.053±0.003 1.729± 0.151 0.115±0.028
ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid).
DPPH (2,2-diphenyl-1-picrylhydrazyl).
ORAC (Oxygen Radical Absorbance Capacity).
NO (Nitric Oxide).
negative side effects because of fast tissue and blood clearance [69].
The bioprospection of this class of molecules is of great interest due to
its wide applications in different industries, including cosmetics [70] or
food industry to control lipid oxidation that produce undesirable off-
flavors and potentially toxic reactions products [71]. Moreover, they
might also be used as leading templates for designing novel molecules
for preventing neurodegeneration.
Acknowledgments
The authors thank of the B2Tech platform facilities (Biochemical
And Biophysical Technologies, Instituto de Investigação e Inovação em
Saúde (I3S) da Universidade do Porto, Portugal) for the use of circular
dichroism (CD). AP is grateful for the Fundação para a Ciência e a
Tecnologia (FCT, Portugal) grants (SFRH/BD/97995/2013) financed by
POPH-QREN (subsidized by FSE and MCTES). NV thanks FCT and
FEDER (European Union) for funding through UID/MULTI/04378/
2013, project grant IF/00092/2014 and IF2014 position. NV thanks
also Fundação Manuel António da Mota (FMAM, Portugal) by support
to Nuno Vale Lab. PG thanks FCT for funding through UID/QUI/50006/
2013. RS and CCP, hold postdoctoral fellowships from FCT (Refs:
SFRH/BPD/91833/2012 and FRH/BPD/91962/2012, respectively).
ACM is grateful to FAPESP (Grants 2014/02282-6 and 2016/18023-5).
YPM is grateful to CNPq by the Senior Researcher Grant (PQ-Sr
306036/2016-9). EAB is grateful to PNPD/CAPES (Grant No:1603966)
for its postdoctoral fellowship. M. M. Marani is a researcher at
CONICET.
Fig. 6. Evaluation of cytotoxicity in NIH3T3 murine fibroblast cells after 24 h exposure to (A) antioxidin-I and (B) antioxidin-RP1 peptides at concentrations ranging from 12.5 to 400 μg/
mL. Viability values are relative to negative control using ultrapure water. Morphology of NIH3T3 cells after 24 h exposure to (C) control, (D) antioxidin-I and (E) antioxidin-RP1 at
400 µg/mL. Asterisks denote statistically significant differences against negative control (P< 0.05).
Fig. 7. (A) Redox status measured by GSSG/GSH-eq ratio and (B) morphology of murine
fibroblasts NIH3T3 exposed to 20 µM menadione, 400 µg/mL antioxidin or both.
Additionally, an ethanol control (menadione vehicle) was assayed. The asterisk denotes
significant difference in relation to all other groups.
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